A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
Clinical trial NCT00413101 · COMPLETED
Trial details
- NCT number
- NCT00413101
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.